Draft NICE guidance welcomed by BHF1st April 2010
The British Heart Foundation has welcomed new draft guidance from the National Institute for Health and Clinical Excellence on Dronedarone.
NICE recommends limited use of dronedarone for atrial fibrillation (AF). June Davison, Senior Cardiac Nurse at the BHF, said the organisations supported the committee's conclusion that dronedarone should not be recommended as a first-line anti-arrhythmic drug on the basis of current evidence, but that dronedarone should be available for people who find their existing drug ineffective or cannot tolerate the drug they are prescribed.
Share this page
There are no comments for this article, be the first to comment!
Post your comment
Only registered users can comment. Fill in your e-mail address for quick registration.
Title: Draft NICE guidance welcomed by BHF
Author: Mark Nicholls
Article Id: 14551
Date Added: 1st Apr 2010